TOP2A and cancer: There are two major forms of topoisomerase-2 (Top2); Top2α is only expressed in proliferating cells and is widely regarded as the main target of doxorubicin's anti-cancer effects, while Top2β is present in all mammalian cells including cardiomyocytes.